Cabinet Plasseraud patent opposition analysis

The comprehensive analysis of Cabinet Plasseraud opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by Cabinet Plasseraud

Patent NumberTitleApplicantOpposition DateOpposition Company
Use Of Chimeric Antigen Receptor-Modified T Cells To Treat CancerTHE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIAJul 3, 2019CABINET PLASSERAUD
Coating CompositionsCARGILLApr 11, 2019ROQUETTE FRRES

Top companies who are the clients of Cabinet Plasseraud